Topical Bacterial Products
Total Trials
14
As Lead Sponsor
13
As Collaborator
1
Total Enrollment
741
NCT04152226
A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 19, 2019
Completion: Apr 30, 2019
NCT04192513
Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo
Start: May 20, 2019
Completion: Jun 30, 2020
NCT04315051
A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis
Start: Sep 12, 2019
NCT04668911
Oral Health, Microbial Burden and COVID-19
Phase: N/A
Role: Collaborator
Start: Dec 13, 2020
Completion: Dec 12, 2021
NCT04937920
A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor
Start: Mar 16, 2021
Completion: Nov 4, 2021
NCT05253755
Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel
Start: Oct 6, 2021
Completion: Sep 9, 2022
NCT05136144
Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis
Start: Oct 19, 2021
Completion: Jul 31, 2024
NCT05511948
Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos
Start: Aug 18, 2022
Completion: Mar 7, 2023
NCT05493488
A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis
Start: Sep 8, 2022
Completion: Dec 31, 2023
NCT06108024
A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis
Start: Nov 6, 2023
Completion: Oct 15, 2024
NCT06099080
A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)
Start: Nov 7, 2023
Completion: Jul 25, 2024
NCT05491603
A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis
Start: Nov 30, 2023
Completion: Nov 30, 2023
NCT06409195
A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers
Start: Mar 25, 2024
Completion: Nov 30, 2024
NCT06454747
Randomized Study Using SM-030 Gel for Adults With Melasma
Start: Jun 27, 2024
Completion: Oct 31, 2025
Loading map...